In 2014, ICAP began implementing the Geographically Concentrated Multi-Level HIV Prevention programme in Bukoba Urban District, Tanzania. The primary goal of this study was to achieve an Antiretroviral Therapy (ART) coverage of more than 80% among eligible adult residents after a 2.5-year community-wide combination prevention intervention.
Prior to the intervention commencing, EDI Global and ICAP implemented a baseline survey, in 2013 and 2014, during which a joint team interviewed over 5,000 respondents in 2,500 households, while ICAP medical staff conducted HIV tests on all consenting respondents. A cohort of 400 respondents who were newly diagnosed as being HIV positive were then re-interviewed within two weeks of the diagnosis and again six months later to track their experiences.
In 2017 and 2018, EDI Global conducted an endline and follow-up survey. This survey was a mirror of the baseline, but using a new sample. For the endline, EDI Global listed the household members of 4,628 households in 47 enumerations areas. Of the 6,844 potentially eligible individuals listed, 5,333 completed the individual (household) interview. A group of 194 HIV positive respondents was recruited (from household interviews and directly from medical facilities) and consented to be part of the cohort study. 175 cohort interviews were completed. The follow-up survey was conducted with 145 eligible cohort respondents to track their experiences of being HIV positive.
EDI Global conducted the baseline, midline, endline, and follow-up surveys for this outcome evaluation. This included the planning, oversight and implementation of:
The findings of the outcome evaluation generated several publications, reports and other materials that are publicly available on the ICAP website.